Can tear drop cells be present in disease processes beyond bone marrow fibrosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Teardrop Cells in Disease Processes Beyond Bone Marrow Fibrosis

While teardrop cells are classically associated with bone marrow fibrosis, they are definitely present in several other disease processes including autoimmune hemolytic anemia, microangiopathic hemolytic anemia, and conditions with extramedullary hematopoiesis. 1, 2, 3

Conditions Associated with Teardrop Cells

Primary Conditions

  • Myelofibrosis - The classic association where teardrop cells are most frequently observed 1
  • Myelodysplastic Syndromes (MDS) - Teardrop cells are a sign of red cell dysplasia 1
  • Infiltrative Bone Marrow Disorders:
    • Multiple myeloma with marrow fibrosis 4
    • Malignant infiltrative disorders of the bone marrow 2

Secondary Conditions

  • Autoimmune Hemolytic Anemia (AIHA) - Present in 89% of cases in one study 2
  • Microangiopathic Hemolytic Anemia (MAHA) - Present in 91% of cases in one study 2
  • Conditions with Extramedullary Hematopoiesis - Particularly when associated with splenomegaly 3
  • Systemic Conditions:
    • Lymphoma (may involve infiltration of bone marrow) 5
    • Sarcoidosis (can cause infiltration of hematopoietic tissues) 5
    • Hemochromatosis (can affect bone marrow function) 5
    • Amyloidosis (can infiltrate bone marrow) 5

Pathophysiological Mechanisms

The presence of teardrop cells in peripheral blood can occur through different mechanisms:

  1. Altered Bone Marrow Architecture - The classic mechanism in myelofibrosis where fibrotic changes distort red cell production 1

  2. Splenic Involvement - Extramedullary hematopoiesis and splenic sequestration can contribute to teardrop formation even without bone marrow fibrosis 3

    • Evidence shows that splenectomy or resolution of splenomegaly can lead to disappearance of teardrop cells in some cases 3
  3. Red Cell Membrane Damage - In hemolytic anemias, damage to red cell membranes may contribute to teardrop formation 2

Clinical Significance and Evaluation

When teardrop cells are identified on peripheral blood smear, consider:

  • Complete blood count to evaluate for cytopenias or other abnormal cell counts 1
  • Peripheral blood smear examination for other red cell abnormalities, dysplastic features in granulocytes, and platelet abnormalities 1
  • Bone marrow examination to evaluate cellularity, dysplasia, blast percentage, and fibrosis 1
  • Molecular testing for mutations associated with myeloid disorders 1
  • Evaluation for hemolytic processes if other findings suggest AIHA or MAHA 2

Important Caveats

  • The presence of teardrop cells should always prompt consideration of bone marrow examination, but the differential diagnosis should be broadened beyond just myelofibrosis 1
  • Teardrop poikilocytosis can be reversible with effective treatment of the underlying condition 6
  • The prevalence of teardrop cells in hemolytic anemias is significantly higher than previously recognized 2
  • When teardrop cells are present with splenomegaly but without bone marrow fibrosis, consider autoimmune processes or extramedullary hematopoiesis 3

Remember that while teardrop cells are a valuable diagnostic clue, they must be interpreted in the context of other clinical and laboratory findings to determine the underlying pathology.

References

Guideline

Diagnosis and Evaluation of Teardrop Cells in Peripheral Blood Smears

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Teardrop-shaped red cells in autoimmune hemolytic anemia.

American journal of hematology, 1986

Research

[IgD-lambda multiple myeloma associated with bone marrow fibrosis].

[Rinsho ketsueki] The Japanese journal of clinical hematology, 1991

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.